Iduronate Sulfatase

Download PDF

Recent Publications on Iduronate Sulfatase:
Idursulfase for the treatment of mucopolysaccharidosis II. Human recombinant proteins are being used to treat an increasing number of...	9th April, 2008	University of British Columbia and the Child and Family Research	Expert Opin Pharmacother. 2008 Feb;9(2):311-7. DOI Direct Link
[Clinical study of enzyme replacement therapy with idursulfase] INTRODUCTION: Important advances have been made in enzyme replacement...	3rd April, 2008	Hospital Infantil Universitario Nino Jesus, 28009 Madrid, Espana.	Rev Neurol. 2007 Feb 19;44 Suppl 1:S7-S11.
Idursulfase in Hunter syndrome treatment. Hunter syndrome (mucopolysaccharidosis II, MPS II) is a rare X-linked...	7th March, 2008	Department of Environmental Medicine, University of Rochester, School of	Drugs Today (Barc). 2007 Nov;43(11):759-67. DOI Direct Link
Enzyme reconstitution/replacement therapy for lysosomal storage diseases. PURPOSE OF REVIEW: Over the past 15 years, the lysosomal storage diseases...	26th February, 2008	Division of Human Genetics, Cincinnati Children's Hospital Medical Center	Curr Opin Pediatr. 2007 Dec;19(6):628-35. DOI Direct Link
[Computational prediction of the tertiary structure of the human iduronate 2-sulfate sulfatase] INTRODUCTION: Hunter syndrome (MC KUSIK 309900) or mucopolysacharidosis...	30th October, 2007	Instituto de Errores Innatos del Metabolismo, Facultad de Ciencias,	Biomedica. 2007 Mar;27(1):7-20. Epub 2007 May 31. DOI Direct Link
→View more research publications.

Iduronate Sulfatase Clinical Trials:
Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase	Hunter Syndrome;   Mucopolysaccharidosis II

Iduronate Sulfatase Patents:
US Patent No.	Title
5929304	Production of lysosomal enzymes in plant-based expression systems
6670194	Rapid quantitative analysis of proteins or protein function in complex mixtures
6730297	Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
6743779	Methods for delivering compounds into a cell
6797265	Deleted adenovirus vectors and methods of making and administering the same
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Iduronate Sulfatase scientists - we have details of around 24 individuals working on Iduronate Sulfatase .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.